Testing alpha-lipoic acid plus mirabegron for weight control
Treatments studied
Part of Hormones & metabolism clinical trials.
This Phase 2 study tests whether a combination medicine—alpha-lipoic acid plus mirabegron—can help people manage obesity. It will study safety and whether the treatment can improve weight-related outcomes in adults.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 to 65
- Your body mass index (BMI) is 30 to 45
- You are not allergic to mirabegron or alpha-lipoic acid
- You do not have serious bladder overactivity or take bladder anticholinist medicines
- You do not have diabetes requiring insulin or diabetes medicines that lower sugar
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether mirabegron and tadalafil can improve blood sugar control in people with prediabetes. It may help determine if these medicines can slow the move from prediabetes toward diabetes.
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.
This study tests whether a new medicine called NNC0487-0111 helps people with type 2 diabetes and excess weight lose weight. You'll take the medicine along with your current diabetes care to see if it works better than standard treatment.
This Phase 2 study tests two medicines to see how they change body fat, insulin sensitivity, and bone health in adults with obesity. It may help people who have tried lifestyle changes to lose weight but have not been able to, though diabetes and several health conditions must be ruled out first.
This trial tests two new medicines, alone or together, to see if they help with weight loss and blood sugar control in adults who have type 2 diabetes and are overweight or have obesity.
Hear when a new Insulin Resistance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.